These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Levofloxacin in first-line treatment of Helicobacter pylori infection. Rispo A; Di Girolamo E; Cozzolino A; Bozzi R; Morante A; Pasquale L Helicobacter; 2007 Aug; 12(4):364-5. PubMed ID: 17669111 [No Abstract] [Full Text] [Related]
7. Isolation and eradication of a clinical isolate of Helicobacter pylori resistant to five antimicrobials in Germany. Wüppenhorst N; Lenze F; Ross M; Kist M J Antimicrob Chemother; 2011 Jan; 66(1):222-3. PubMed ID: 21051371 [No Abstract] [Full Text] [Related]
8. Bismuth-containing quadruple therapy as second-line treatment for Helicobacter pylori infection: effect of treatment duration and antibiotic resistance on the eradication rate in Korea. Lee BH; Kim N; Hwang TJ; Lee SH; Park YS; Hwang JH; Kim JW; Jeong SH; Lee DH; Jung HC; Song IS Helicobacter; 2010 Feb; 15(1):38-45. PubMed ID: 20302588 [TBL] [Abstract][Full Text] [Related]
9. Efficacy of metronidazole as second-line drug for the treatment of Helicobacter pylori Infection in the Japanese population: a multicenter study in the Tokyo Metropolitan Area. Matsuhisa T; Kawai T; Masaoka T; Suzuki H; Ito M; Kawamura Y; Tokunaga K; Suzuki M; Mine T; Takahashi S; Sakaki N Helicobacter; 2006 Jun; 11(3):152-8. PubMed ID: 16684262 [TBL] [Abstract][Full Text] [Related]
10. The relationship between previous fluoroquinolone use and levofloxacin resistance in Helicobacter pylori infection. Carothers JJ; Bruce MG; Hennessy TW; Bensler M; Morris JM; Reasonover AL; Hurlburt DA; Parkinson AJ; Coleman JM; McMahon BJ Clin Infect Dis; 2007 Jan; 44(2):e5-8. PubMed ID: 17173210 [TBL] [Abstract][Full Text] [Related]
11. Meta-analysis: the effect of antibiotic resistance status on the efficacy of triple and quadruple first-line therapies for Helicobacter pylori. Fischbach L; Evans EL Aliment Pharmacol Ther; 2007 Aug; 26(3):343-57. PubMed ID: 17635369 [TBL] [Abstract][Full Text] [Related]
12. [Is antimicrobial susceptibility testing necessary before second-line treatment for Helicobacter pylori infection?]. Nagahara A; Sato N Nihon Rinsho; 2005 Nov; 63 Suppl 11():421-5. PubMed ID: 16363572 [No Abstract] [Full Text] [Related]
13. [Failure in the eradication of Helicobacter pylori: the role of antibiotic resistance]. Lengyel G; Zsolt T Orv Hetil; 2005 May; 146(18):839-42. PubMed ID: 15926629 [TBL] [Abstract][Full Text] [Related]
14. Management of Helicobacter pylori infection. Eradication treatment can be tailored in patients undergoing endoscopy. Parsons HK; Sanders DS; Carter MJ; Lobo AJ BMJ; 2002 Mar; 324(7337):614. PubMed ID: 11887888 [No Abstract] [Full Text] [Related]
15. Eradication therapy for Helicobacter pylori. Vakil N; Megraud F Gastroenterology; 2007 Sep; 133(3):985-1001. PubMed ID: 17854602 [TBL] [Abstract][Full Text] [Related]
16. Therapy of Helicobacter pylori. McLoughlin R; Racz I; Buckley M; O'Connor HJ; O'Morain C Helicobacter; 2004; 9 Suppl 1():42-8. PubMed ID: 15347305 [TBL] [Abstract][Full Text] [Related]
17. Quinolone resistance in Helicobacter pylori isolates in Germany. Glocker E; Stueger HP; Kist M Antimicrob Agents Chemother; 2007 Jan; 51(1):346-9. PubMed ID: 17043117 [TBL] [Abstract][Full Text] [Related]
18. Helicobacter pylori infection: sequential therapy followed by levofloxacin-containing triple therapy provides a good cumulative eradication rate. Manfredi M; Bizzarri B; de'Angelis GL Helicobacter; 2012 Aug; 17(4):246-53. PubMed ID: 22759323 [TBL] [Abstract][Full Text] [Related]
20. Resistance of Helicobacter pylori to antibiotics and its impact on treatment options. Mégraud F Drug Resist Updat; 2001 Jun; 4(3):178-86. PubMed ID: 11768331 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]